Shock — Distributive and Septic

Loss of Systemic Vascular Resistance and Vasodilation

• Nitric oxide (NO) overproduction from inducible NO synthase (iNOS) in response to lipopolysaccharide (LPS) and inflammatory cytokines causes profound vasodilation and decreased systemic vascular resistance
• Bradykinin and other vasoactive mediators released from activated mast cells and endothelial cells contribute to increased vascular permeability
• Dysregulation of endothelin-1 and angiotensin II leads to loss of compensatory vasoconstriction
• Activation of ATP-sensitive potassium channels in vascular smooth muscle perpetuates vasodilation despite catecholamine stimulation

Inflammatory Cascade and Cytokine Storm

• Recognition of pathogen-associated molecular patterns (PAMPs) by toll-like receptors (TLRs) activates macrophages and dendritic cells
• Massive release of TNF-α, IL-1β, IL-6, and IL-8 creates a pro-inflammatory milieu that amplifies endothelial activation
• Complement system activation (particularly C5a) promotes neutrophil recruitment, leukocyte adhesion, and further endothelial damage
• Dysregulated anti-inflammatory response with elevated IL-10 and TGF-β leads to immunosuppression and impaired pathogen clearance

Capillary Leak and Fluid Maldistribution

• Endothelial tight junction disruption via VE-cadherin shedding and increased expression of adhesion molecules allows interstitial fluid accumulation
• Increased bradykinin and histamine-mediated vascular permeability results in third-spacing and relative hypovolemia despite adequate intravascular volume
• Loss of glycocalyx on endothelial surface reduces oncotic pressure gradient, promoting fluid extravasation

Myocardial Dysfunction and Cellular Energy Failure

• Myocardial depressant substances (circulating TNF-α, IL-1β, and endotoxin) directly impair contractility despite initially elevated cardiac output
• Mitochondrial dysfunction with impaired oxidative phosphorylation occurs secondary to circulating inflammatory mediators and inadequate oxygen delivery
• Increased expression of inducible NOS in cardiomyocytes produces excessive NO, which uncouples electron transport and reduces ATP generation
• Septic cardiomyopathy develops in 25-50% of septic patients, presenting as decreased ejection fraction with dilation that is typically reversible
• Lactate accumulation results from both increased anaerobic metabolism and impaired hepatic clearance due to mitochondrial dysfunction

Coagulopathy and Microvascular Thrombosis

• Tissue factor upregulation on monocytes triggers the extrinsic coagulation pathway while simultaneously suppressing fibrinolysis via increased plasminogen activator inhibitor-1 (PAI-1)
• Consumption of platelets and coagulation factors in disseminated intravascular coagulation (DIC) leads to concurrent bleeding and thrombosis
• Neutrophil extracellular traps (NETs) ensnare pathogens but also promote thrombosis and contribute to organ damage
• Microvascular thrombosis impairs perfusion at the tissue level despite macrocirculatory compensation

Septic Shock (Primary Distributive Shock)

• Gram-negative bacteria (Escherichia coli, Klebsiella, Pseudomonas aeruginosa, Acinetobacter baumannii)
• Gram-positive bacteria (Staphylococcus aureus including methicillin-resistant strains, Streptococcus pneumoniae, Group B Streptococcus)
• Fungal pathogens (Candida albicans and non-albicans species, Aspergillus)
• Viral pathogens (influenza, COVID-19, dengue fever)
• Common infection sources: pneumonia (most common ~40%), urinary tract infection, intra-abdominal infection, bacteremia/bloodstream infection, skin and soft tissue infection

Non-Septic Distributive Shock

• Anaphylaxis from food allergens (peanuts, shellfish), medications (penicillins, ACE inhibitors), insect venom, latex
• Neurogenic shock from spinal cord injury (typically T6 or above) causing loss of sympathetic tone
• Thyroid storm from massive thyroid hormone release in uncontrolled hyperthyroidism
• Toxic shock syndrome from Staphylococcus aureus or Streptococcus pyogenes producing superantigen toxins
• Drug-induced (chemotherapy cytokine release, immune checkpoint inhibitor adverse events)

Risk Factors for Sepsis Development

• Advanced age (>65 years)
• Immunocompromised states: HIV/AIDS with CD4 <50, hematologic malignancies, organ transplantation, chronic corticosteroid use
• Comorbid conditions: diabetes mellitus, chronic renal disease, cirrhosis, chronic obstructive pulmonary disease
• Healthcare-associated: recent hospitalization, invasive procedures, indwelling catheters, mechanical ventilation
• Functional or anatomic asplenia
• Recent surgery or instrumentation
• Extremes of age (neonates and elderly)

Early Sepsis (Recognition is Critical for Outcome)

• Fever (or hypothermia in severe cases, which carries worse prognosis) with chills and rigors
• Tachycardia >90 bpm (compensatory response to decreased systemic vascular resistance)
• Tachypnea >20 breaths/min with respiratory alkalosis from hyperventilation
• Altered mental status ranging from agitation to confusion to lethargy (reflects inadequate cerebral perfusion and inflammatory encephalopathy)
• Source identification: localized symptoms depending on infection source (productive cough with pneumonia, dysuria with UTI, abdominal pain with intra-abdominal infection)

Hemodynamic Features

• "Warm shock" (early/hyperdynamic phase): warm, erythematous skin with brisk capillary refill despite hypotension, reflecting peripheral vasodilation and maintained cardiac output
• "Cold shock" (late/hypodynamic phase): cool, clammy extremities with delayed capillary refill, mottled skin, reflecting severe vasoconstriction as compensation fails
• Hypotension defined as systolic blood pressure <90 mmHg or mean arterial pressure (MAP) <65 mmHg for >1 hour despite adequate fluid resuscitation
• Bounding pulses in early sepsis due to wide pulse pressure from vasodilation (pulse pressure = systolic - diastolic)
• Tachycardia out of proportion to fever suggests inadequate compensation

Organ Dysfunction Manifestations

• Pulmonary: acute respiratory distress syndrome (ARDS) with bilateral infiltrates, hypoxemia (SpO2 <90% on room air), increased work of breathing
• Renal: oliguria (<0.5 mL/kg/hr), rising creatinine indicating acute kidney injury, inability to concentrate urine
• Hepatic: jaundice, elevated bilirubin, prolonged PT/INR, hepatic encephalopathy
• Hematologic: thrombocytopenia from consumption in DIC, bleeding from mucosal surfaces or puncture sites
• Skin: petechiae and purpura (especially with meningococcemia), erythematous maculopapular rash (viral exanthems)
• Gastrointestinal: ileus with abdominal distension, stress ulceration with upper GI bleeding

Anaphylaxis-Specific Features

• Rapid onset (minutes to hours) of symptoms after exposure to known or suspected trigger
• Urticaria and angioedema with pruritus
• Bronchospasm with wheezing and stridor
• Cardiovascular collapse with syncope
• Gastrointestinal symptoms: nausea, vomiting, diarrhea, cramping

Neurogenic Shock-Specific Features

• Bradycardia (unusual in distributive shock) with hypotension
• History of spinal cord trauma or transection above T6
• Loss of sweating below level of injury
• Poikilothermia (body temperature reflects environment)

Clinical Diagnosis: Sepsis-3 Definitions (2016 Consensus)

• Infection (suspected or documented) PLUS systemic inflammatory response manifested by altered mental status (GCS <15), systolic hypotension (≤100 mmHg), or respiratory rate ≥22 breaths/min
• Sepsis = infection + SIRS criteria OR dysfunction of one or more organ system
• Septic shock = sepsis + hypotension (SBP <90 or MAP <65 mmHg) requiring vasopressors to maintain perfusion AND serum lactate >2 mmol/L despite adequate fluid resuscitation
• Note: Earlier criteria (SIRS) are less specific; Sepsis-3 focuses on organ dysfunction via qSOFA score (altered mental status, SBP ≤100 mmHg, respiratory rate ≥22)

Laboratory Tests

• Complete blood count (CBC): leukocytosis (>11,000) or leukopenia (<4,000) indicating infection or severe immunosuppression; thrombocytopenia (<100,000) suggests DIC
• Serum lactate (most important prognostic marker): elevated lactate (>2 mmol/L) indicates tissue hypoperfusion and anaerobic metabolism; each mmol/L increase associated with 8% increased mortality; persistent elevation after resuscitation is poor prognostic sign
• Comprehensive metabolic panel: elevated creatinine indicating acute kidney injury, hyperglycemia from stress response and insulin resistance, hypocalcemia, hyponatremia
• Liver function tests: elevated transaminases, elevated bilirubin, prolonged PT/INR from hepatic synthesis dysfunction
• Coagulation studies: prolonged PT/PTT, elevated D-dimer, low fibrinogen, elevated fibrin degradation products indicating DIC
• Blood cultures (2 sets minimum before antibiotics): gold standard for pathogen identification, guide targeted antimicrobial therapy; positive cultures in <70% of septic shock cases
• Procalcitonin: elevation >0.5 ng/mL suggests bacterial infection; less specific than once thought but useful for treatment de-escalation decisions
• C-reactive protein (CRP): markedly elevated (>100 mg/L) in sepsis; nonspecific
• Urinalysis and urine culture: if UTI suspected as source
• Cerebrospinal fluid (CSF) analysis: if meningitis suspected with cell count, glucose, protein, culture, Gram stain

Imaging Studies

• Chest X-ray: bilateral infiltrates in ARDS, infiltrates in pneumonia source, pulmonary edema from fluid resuscitation
• Abdominal/pelvic CT with IV contrast: identifies intra-abdominal source such as perforation, abscess, appendicitis, cholecystitis, diverticulitis
• Bedside echocardiography: assesses left ventricular ejection fraction (reduced in septic cardiomyopathy), right ventricular function, pericardial effusion, guides fluid responsiveness assessment via IVC diameter and collapsibility
• Lactate clearance imaging: not routinely performed but persistent elevated lactate on serial measurements indicates tissue hypoperfusion despite resuscitation

Hemodynamic Assessment

• Central venous pressure (CVP) monitoring via central line: goal CVP 8-12 mmHg (15-18 mmHg if mechanically ventilated)
• Mean arterial pressure (MAP): goal ≥65 mmHg
• Cardiac output assessment: pulmonary artery catheter (PAC) provides thermodilution cardiac output, mixed venous oxygen saturation (SvO2), and systemic vascular resistance calculation; less commonly used in contemporary practice but useful in refractory shock
• Fluid responsiveness assessment: passive leg raise test increases preload; if cardiac output increases by >10%, patient is fluid-responsive; IVC collapsibility >50% suggests fluid responsiveness
• ScvO2 (central venous oxygen saturation) monitoring: goal >70% reflects adequate oxygen delivery; if <70% despite fluid resuscitation and vasopressors, indicates persistent tissue hypoperfusion

Immediate Resuscitation (Within First Hour — "Golden Hour")

• Fluid resuscitation: 30 mL/kg crystalloid (normal saline or balanced crystalloid such as lactated Ringer's) as rapid bolus over 10-30 minutes, reassess responsiveness
• Vasopressors for refractory hypotension: initiate if MAP remains <65 mmHg after initial fluid bolus
• Norepinephrine (first-line agent): α-adrenergic (vasoconstriction) and β-adrenergic (mild inotropic) effects; dosing 0.01-0.05 mcg/kg/min titrated to MAP goal
• Dopamine (second-line): at doses 5-20 mcg/kg/min provides both inotropy and vasoconstriction; increased arrhythmia risk compared to norepinephrine
• Phenylephrine (pure α-agonist): used only if concurrent tachycardia or arrhythmia concerns; 0.4-0.6 mcg/kg/min
• Epinephrine: reserved for refractory hypotension despite norepinephrine; higher doses (0.1-0.5 mcg/kg/min) increase lactate and mortality risk
• Inotropic agents if decreased cardiac contractility despite adequate preload and vasopressor support:
• Dobutamine: β-2 agonist causing inotropy and vasodilation; 2-20 mcg/kg/min; may cause hypotension and tachycardia
• Milrinone: phosphodiesterase-3 inhibitor providing inotropic and vasodilatory effects; useful in cardiogenic component of septic shock; avoid in hypotension unless combined with vasopressors
• Early antibiotics: within 1 hour of recognition (or 3 hours if outside hospital setting), empiric broad-spectrum coverage before cultures return
• Pneumonia source: ceftriaxone 1-2 g IV Q12H or piperacillin-tazobactam 4.5 g IV Q6-8H; add macrolide if atypical pathogens suspected
• Abdominal source: ceftriaxone or piperacillin-tazobactam PLUS metronidazole for anaerobic coverage
• UTI/gram-negative source: fluoroquinolone or third-generation cephalosporin
• Community-acquired methicillin-resistant S. aureus (MRSA) risk: add vancomycin (15-20 mg/kg IV Q8-12H with AUC-guided monitoring, AUC/MIC 400-600 per the 2020 IDSA/ASHP consensus) or linezolid
• Fungal coverage: consider in immunocompromised patients or prior prolonged antibiotic exposure; add fluconazole or echinocandin
• Source control: urgent removal/drainage of infected material (infected catheter, abscess drainage, surgical debridement for necrotizing soft tissue infection, fasciotomy for compartment syndrome)

Ongoing Management and Monitoring

• Lactate-guided resuscitation: measure initial lactate and reassess at 6 hours; persistent elevation

Complications of the shock state

• Acute respiratory distress syndrome: capillary leak floods alveoli with protein-rich fluid; signaled by worsening hypoxemia with bilateral infiltrates not explained by heart failure. Requires lung-protective ventilation (low tidal volume, plateau pressure limited) per the ATS/ESICM/SCCM ARDS guideline. Emergency.
• Acute kidney injury: combined hypoperfusion, microvascular thrombosis, and inflammatory tubular injury; signaled by oliguria and rising creatinine (KDIGO staging). Refractory hyperkalemia, acidosis, or uremia mandates urgent dialysis.
• Disseminated intravascular coagulation: tissue-factor–driven consumption; signaled by falling platelets, prolonged PT/aPTT, low fibrinogen, rising D-dimer, with oozing from puncture sites. Purpura fulminans with symmetric peripheral gangrene (classically meningococcemia) is an emergency.
• Septic cardiomyopathy: cytokine- and NO-mediated contractile depression; signaled by a new low ejection fraction with rising filling pressures despite pressors — reversible, but demands inotropic support.
• Ischemic hepatitis and gut ischemia: transaminases in the thousands, or out-of-proportion abdominal pain with worsening lactate. Bowel infarction is a surgical emergency.
• Critical illness–related corticosteroid insufficiency: persistent pressor dependence despite adequate volume; the Surviving Sepsis Campaign suggests IV hydrocortisone in this setting.
• Critical illness myopathy/polyneuropathy and post-sepsis cognitive impairment: flaccid weakness and failure to wean.

Complications of treatment

• Fluid overload: over-resuscitation past the point of fluid responsiveness causes pulmonary edema, worsening oxygenation, and abdominal compartment syndrome.
• Hyperchloremic metabolic acidosis: large-volume normal saline; a reason many favor balanced crystalloid.
• Vasopressor extravasation: α-mediated local vasoconstriction produces blanching and skin necrosis — treat promptly with local phentolamine infiltration. Emergency.
• Digital and mesenteric ischemia: high-dose norepinephrine/vasopressin; mottled, dusky digits.
• Tachyarrhythmias: dopamine and epinephrine; epinephrine also raises lactate, confounding resuscitation targets.
• Antimicrobial harm: vancomycin/piperacillin-tazobactam nephrotoxicity, C. difficile colitis, and resistance selection — hence de-escalation once cultures return.
• Central line placement: pneumothorax, arterial puncture, and later catheter-related bloodstream infection.

• The hemodynamic triad is the single most tested fact: distributive shock = high cardiac output, low systemic vascular resistance, low/normal wedge pressure. Cardiogenic shock is low CO / high SVR / high wedge; hypovolemic is low CO / high SVR / low wedge; obstructive (tamponade, massive PE, tension pneumothorax) is low CO / high SVR with elevated right-sided pressures.
• Elevated ScvO₂ or mixed venous saturation in a hypotensive, lactate-elevated patient points to sepsis, not cardiogenic shock — oxygen extraction fails at the mitochondrial and microcirculatory level. A low SvO₂ is the cardiogenic distractor.
• Single best next step in undifferentiated septic shock: obtain blood cultures and lactate, then give broad-spectrum antibiotics and 30 mL/kg crystalloid — but the Surviving Sepsis Campaign is explicit that antibiotics must not be delayed for cultures or imaging in shock.
• Norepinephrine is first-line vasopressor (Surviving Sepsis Campaign); vasopressin is the usual add-on to spare catecholamine dose. Dopamine is the classic wrong answer because of arrhythmia risk. Pressors may be started peripherally rather than waiting for central access.
• Anaphylaxis: IM epinephrine 0.3–0.5 mg in the anterolateral thigh is the immediate answer (AAAAI/ACAAI Joint Task Force). Antihistamines, corticosteroids, and H2 blockers are adjuncts only — choosing them first is the trap. Watch for a biphasic reaction hours later.
• Neurogenic shock is the distributive shock with bradycardia — warm, dry, flushed skin below a cord lesion at or above T6 from unopposed vagal tone. Hypovolemic shock from occult hemorrhage in the same trauma patient is the distractor.
• Toxic shock syndrome: staphylococcal or streptococcal superantigens cross-link MHC II to the TCR Vβ region, causing polyclonal T-cell activation; look for diffuse macular erythroderma with later desquamation of palms and soles and negative blood cultures in the staphylococcal form.
• Persistently elevated lactate after resuscitation predicts death and signals inadequate source control — look for the undrained abscess or necrotizing soft tissue infection.